what not to do on tirzepatide Your journey starts with smart choices. At Just Melt Medspa, we're here guide you every step of the way—because success isn't just about the treatment, it's about you Why You're Not Losing Weight

03 MEET YOUR PERSONAL PROVIDER Receive a plan designed to help you reach your goals

Orforglipron is not yet licensed in the UK for weight loss

The ideal spacing for a twice-weekly protocol is 72-84 hours

At least one serious adverse event occurred among 10.9% of the 36 mg orforglipron group, 10.3% of the 12 mg orforglipron group, 7.3% of those receiving 6 mg orforglipron and 8.8% of the placebo group

SGLT2 inhibitor use is associated with a reduction in both fat mass and lean body mass (measured using a range of techniques) similar to that caused by GLP-1 receptor agonists

DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) such as sitagliptin, linagliptin, or saxagliptin offer another alternative